The Global Single-Cell Bioinformatics Software and Services market size was valued at US$ 235.35 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.17% from 2022 to 2030. The single-Cell bioinformatics tool enables researchers to easily identify and explore subpopulations and differentially expressed genes while generating publication-ready figures. The sequencing software provides transcriptional profiling of numerous individual cells. This level of comprehensive throughput analysis enables researchers to comprehend, at the level of a single cell, which genes are expressed, in what amounts, and how they vary across thousands of cells in a heterogeneous sample. It will detect single-Cells genomes, transcriptomes, and other multi-omics. The software can show the differences and evolutionary relationships of various cells.
Factors responsible for the market growth are fast development in Single-Cell Technologies and Advancements in disease diagnosis and drug Discovery. In addition, biopharmaceutical companies are continuously investing in single-Cell sequencing research. Developers are updating their technologies for more detailed and user-friendly, which will boost the rapid growth of the single-Cell bioinformatics software and services market. In Jan 2022, Illumina Enters Co-Development Partnership with SomaLogic will Accelerate Next-Generation Sequencing into the Fastest-Growing Area of the Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow. The competition in sequencing software services is boosting the market's growth due to decreasing sequencing costs.
However, Barriers to Carry Out Effective Single-Cell Analysis, Analytical Challenges in Metabolite Analysis, and Lack of Spatial-Temporal Context are market growth restrainers. High capital requirements and lack of infrastructure and expertise are challenges in front of the single-Cell bioinformatics services market. On the other hand, the market also has some opportunities in the coming years as expansions continuously go into new research applications and product portfolios.
Products, applications, and end-user segment the Global Single-Cell Bioinformatics Software and Services Market. The product segment includes bioinformatics software and bioinformatics services, which the software market will lead the segment due to competition in service providers. By application, this bioinformatics market is divided into Oncology, Immunology, Neurology, Non-invasive Prenatal Diagnosis (NIPD), Microbiology, and Other Applications. Oncological applications are increasing as several patients have cancer. Research and Academic Institutes, Biopharmaceutical Companies, and Others are subsegments of the End-User segment.
North America and Europe generate the highest revenue due to research and development advancements in the single-cell analysis services market. The demand for single-Cell RNA sequencing is more elevated in European countries, which will continue in the coming forecasting years.
Prominent market players are Illumina, Inc., QIAGEN N.V., BD., PacBio, Fluidigm Corporation, NanoString, Takara Bio Inc., BGI, Oxford Nanopore Technologies plc., Partek, Incorporated, Akoya Biosciences, Inc., IsoPlexis, Scipio Bioscience, Scailyte, BioBam Spain, and other.
